Target intelligence / Profile preview

Triglyceride (TG) (TG)

Target
TG
Molecular classification
Other
01

Overview

Triglycerides, or triacylglycerols, are the primary form of energy storage in humans and a major dietary lipid component, consisting of a glycerol backbone esterified with three fatty acids (Source: PubChem, StatPearls). In enteral formulas, they serve as a critical caloric source for patients unable to consume food orally, often provided in varying ratios of Medium-Chain Triglycerides (MCTs) and Long-Chain Triglycerides (LCTs) to optimize absorption (Source: NIH, Mayo Clinic). MCTs are absorbed directly into the portal circulation, making them useful for patients with malabsorption, while LCTs require bile salts and lymphatic transport (Source: StatPearls). Although triglycerides are nutrients rather than traditional therapeutic targets like receptors, their metabolism is a key focus of drug therapy. For instance, the drug orlistat inhibits gastric and pancreatic lipases to prevent the breakdown and absorption of triglycerides for the treatment of obesity (Source: FDA, PubChem). Additionally, medications such as fibrates and omega-3 fatty acids are used to lower elevated plasma triglyceride levels, thereby reducing the risk of cardiovascular disease and acute pancreatitis (Source: Mayo Clinic, StatPearls).

Other names
TriacylglycerolTAGFatMedium-chain triglyceridesLong-chain triglyceridesMCTLCT
02

Mechanism of action

Triglycerides are dietary nutrients and metabolic substrates rather than therapeutic targets. Drugs affecting them typically act by inhibiting digestive enzymes like pancreatic lipase (e.g., orlistat) or by modulating transcriptional regulators of lipid metabolism like PPAR-alpha (e.g., fibrates) to alter systemic levels (Source: PubChem, StatPearls).

03

Biological functions

Other
04

Disease associations

Cardiovascular diseaseOther
05

Safety considerations

SteatorrheaEssential fatty acid deficiencyHypertriglyceridemia-induced pancreatitisGastrointestinal distress
06

Interacting drugs

Orlistat

5 more in the full profile.

07

Biomarkers

Serum triglyceride levelsFecal fat contentChylomicron levels

Beyond the preview

Go deeper on Triglyceride (TG) (TG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Triglyceride (TG) (TG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call